• Je něco špatně v tomto záznamu ?

Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands

D. Laaf, P. Bojarová, H. Pelantová, V. Křen, L. Elling,

. 2017 ; 28 (11) : 2832-2840. [pub] 20171018

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016306

Galectin-3 (Gal-3), a member of the β-galactoside-binding lectin family, is a tumor biomarker and involved in tumor angiogenesis and metastasis. Gal-3 is therefore considered as a promising target for early cancer diagnosis and anticancer therapy. We here present the synthesis of a library of tailored multivalent neo-glycoproteins and evaluate their Gal-3 binding properties. By the combinatorial use of glycosyltransferases and chemo-enzymatic reactions, we first synthesized a set of N-acetyllactosamine (Galβ1,4GlcNAc; LacNAc type 2)-based oligosaccharides featuring five different terminating glycosylation epitopes, respectively. Neo-glycosylation of bovine serum albumin (BSA) was accomplished by dialkyl squarate coupling to lysine residues resulting in a library of defined multivalent neo-glycoproteins. Solid-phase binding assays with immobilized neo-glycoproteins revealed distinct affinity and specificity of the multivalent glycan epitopes for Gal-3 binding. In particular, neo-glycoproteins decorated with N',N″-diacetyllactosamine (GalNAcβ1,4GlcNAc; LacdiNAc) epitopes showed high selectivity and were demonstrated to capture Gal-3 from human serum with high affinity. Furthermore, neo-glycoproteins with terminal biotinylated LacNAc glycan motif could be utilized as Gal-3 detection agents in a sandwich enzyme-linked immunosorbent assay format. We conclude that, in contrast to antibody-based capture steps, the presented neo-glycoproteins are highly useful to detect functionally intact Gal-3 with high selectivity and avidity. We further gain novel insights into the binding affinity of Gal-3 using tailored multivalent neo-glycoproteins, which have the potential for an application in the context of cancer-related biomedical research.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016306
003      
CZ-PrNML
005      
20180517140453.0
007      
ta
008      
180515s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.bioconjchem.7b00520 $2 doi
035    __
$a (PubMed)28976746
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Laaf, Dominic $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 20, 52074 Aachen, Germany.
245    10
$a Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands / $c D. Laaf, P. Bojarová, H. Pelantová, V. Křen, L. Elling,
520    9_
$a Galectin-3 (Gal-3), a member of the β-galactoside-binding lectin family, is a tumor biomarker and involved in tumor angiogenesis and metastasis. Gal-3 is therefore considered as a promising target for early cancer diagnosis and anticancer therapy. We here present the synthesis of a library of tailored multivalent neo-glycoproteins and evaluate their Gal-3 binding properties. By the combinatorial use of glycosyltransferases and chemo-enzymatic reactions, we first synthesized a set of N-acetyllactosamine (Galβ1,4GlcNAc; LacNAc type 2)-based oligosaccharides featuring five different terminating glycosylation epitopes, respectively. Neo-glycosylation of bovine serum albumin (BSA) was accomplished by dialkyl squarate coupling to lysine residues resulting in a library of defined multivalent neo-glycoproteins. Solid-phase binding assays with immobilized neo-glycoproteins revealed distinct affinity and specificity of the multivalent glycan epitopes for Gal-3 binding. In particular, neo-glycoproteins decorated with N',N″-diacetyllactosamine (GalNAcβ1,4GlcNAc; LacdiNAc) epitopes showed high selectivity and were demonstrated to capture Gal-3 from human serum with high affinity. Furthermore, neo-glycoproteins with terminal biotinylated LacNAc glycan motif could be utilized as Gal-3 detection agents in a sandwich enzyme-linked immunosorbent assay format. We conclude that, in contrast to antibody-based capture steps, the presented neo-glycoproteins are highly useful to detect functionally intact Gal-3 with high selectivity and avidity. We further gain novel insights into the binding affinity of Gal-3 using tailored multivalent neo-glycoproteins, which have the potential for an application in the context of cancer-related biomedical research.
650    _2
$a aminocukry $x chemická syntéza $x chemie $x metabolismus $7 D000606
650    _2
$a zvířata $7 D000818
650    _2
$a skot $7 D002417
650    _2
$a techniky kombinatorické chemie $7 D020650
650    _2
$a galektin 3 $x antagonisté a inhibitory $x metabolismus $7 D037502
650    _2
$a glykoproteiny $x chemická syntéza $x chemie $x metabolismus $x farmakologie $7 D006023
650    _2
$a glykosylace $7 D006031
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    _2
$a oligosacharidy $x chemická syntéza $x chemie $x metabolismus $7 D009844
650    _2
$a vazba proteinů $7 D011485
650    _2
$a sérový albumin hovězí $x chemická syntéza $x chemie $x metabolismus $x farmakologie $7 D012710
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bojarová, Pavla $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, 14220 Prague, Czech Republic.
700    1_
$a Pelantová, Helena $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, 14220 Prague, Czech Republic.
700    1_
$a Křen, Vladimír $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, 14220 Prague, Czech Republic.
700    1_
$a Elling, Lothar $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 20, 52074 Aachen, Germany.
773    0_
$w MED00006454 $t Bioconjugate chemistry $x 1520-4812 $g Roč. 28, č. 11 (2017), s. 2832-2840
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28976746 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517140630 $b ABA008
999    __
$a ok $b bmc $g 1299930 $s 1013146
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 28 $c 11 $d 2832-2840 $e 20171018 $i 1520-4812 $m Bioconjugate chemistry $n Bioconjug Chem $x MED00006454
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...